Hartford Financial Management Inc. - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 53 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Hartford Financial Management Inc. ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$340,564
-14.9%
45,3480.0%0.09%
-12.1%
Q2 2023$400,423
+16.4%
45,348
+9.7%
0.10%
+11.2%
Q1 2023$344,016
-10.1%
41,348
+3.8%
0.09%
-11.9%
Q4 2022$382,541
+18.4%
39,8480.0%0.10%
+6.3%
Q3 2022$323,000
+64.0%
39,848
+14.3%
0.10%
+72.7%
Q2 2022$197,000
+1.0%
34,8480.0%0.06%
+17.0%
Q1 2022$195,000
+27.5%
34,8480.0%0.05%
+30.6%
Q4 2021$153,000
-43.8%
34,848
+20.8%
0.04%
-47.8%
Q3 2021$272,000
+29.5%
28,8480.0%0.07%
+32.7%
Q2 2021$210,0000.0%28,848
-14.8%
0.05%0.0%
Q1 2021$210,000
-27.3%
33,848
-12.9%
0.05%
-32.5%
Q4 2020$289,000
+23.0%
38,8480.0%0.08%
+10.0%
Q3 2020$235,000
-43.2%
38,848
-21.6%
0.07%
-47.0%
Q2 2020$414,000
+65.6%
49,548
+17.6%
0.13%
+32.0%
Q1 2020$250,000
+10.1%
42,148
+20.4%
0.10%
+40.8%
Q4 2019$227,000
+57.6%
35,000
+16.7%
0.07%
+47.9%
Q3 2019$144,000
+77.8%
30,000
+47.8%
0.05%
+77.8%
Q2 2019$81,000
+35.0%
20,300
+65.0%
0.03%
+28.6%
Q1 2019$60,000
-6.2%
12,300
+23.0%
0.02%
-12.5%
Q4 2018$64,000
-22.0%
10,0000.0%0.02%
-14.3%
Q3 2018$82,000
-28.7%
10,000
-9.1%
0.03%
-31.7%
Q2 2018$115,000
+6.5%
11,000
+22.2%
0.04%
-25.5%
Q1 2018$108,000
+414.3%
9,000
+318.6%
0.06%
+450.0%
Q4 2017$21,000
+75.0%
2,150
+87.0%
0.01%
+66.7%
Q3 2017$12,0001,1500.01%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 2,433,230$18,128,0008.76%
Solas Capital Management, LLC 800,000$5,960,0004.55%
Southpoint Capital Advisors LP 4,077,214$30,375,0000.53%
683 Capital Management, LLC 1,110,000$8,269,0000.39%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 40,000$298,0000.26%
Avoro Capital Advisors LLC 1,670,000$12,442,0000.21%
Eventide Asset Management 1,120,000$8,344,0000.13%
Hartford Financial Management Inc. 38,848$289,0000.08%
Granahan Investment Management 394,810$2,941,0000.07%
Planned Solutions, Inc. 800$6,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders